Abstract
AbstractMassive hemorrhage following tissue trauma has high mortality owing to the lack of timely intervention. However, research on utilizing hemostats for humans is limited; therefore, developing an efficient emergency hemostatic agent is imperative. We developed a hemostatic sponge using natural polysaccharide riclin, theoretically modified with 50% aldehyde content (AR50). The AR50 sponge, with quasi-honeycomb channels and appropriate aldehyde content, exhibits ultra-high blood absorption (59.4 g·g−1) and rapidly targets erythrocytes and platelets to form a stable barrier. It surpasses most commercial hemostats in porcine artery scission (reducing hemostasis time and blood loss by 53 s and 4.2 g), hepatic bleeding laceration (68 s and 2.6 g), and perforation models (140 s and 4.9 g). The AR50 sponge is easily removed post hemostasis, exhibits antibacterial properties by destroying bacterial cell walls, and is safely absorbed by day 5, making it an ideal emergency hemostatic agent for massive hemorrhages in humans.
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. Fisher, A. D., Bulger, E. M. & Gestring, M. L. Stop the bleeding: educating the public. JAMA 320, 589–590 (2018).
2. Rossaint, R. et al. The STOP the Bleeding Campaign. Crit. Care. 17, 136 (2013).
3. Hickman, D. S. A., Pawlowski, C. L., Sekhon, U. D. S., Marks, J. & Gupta, A. S. Biomaterials and advanced technologies for hemostatic management of bleeding. Adv. Mater. 30, 1700859 (2018).
4. Li, X. et al. Emerging materials for hemostasis. Coord. Chem. Rev. 475, 214823 (2023).
5. Nepal, A., Tran, H., Nguyen, N. T. & Thu Ta, H. Advances in haemostatic sponges: Characteristics and the underlying mechanisms for rapid haemostasis. Bioact. Mater. 27, 231–256 (2023).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献